BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16829334)

  • 1. An exploration of Latino smokers and the use of pharmaceutical aids.
    Levinson AH; Borrayo EA; Espinoza P; Flores ET; Pérez-Stable EJ
    Am J Prev Med; 2006 Aug; 31(2):167-71. PubMed ID: 16829334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour.
    Hammond D; McDonald PW; Fong GT; Borland R
    Addiction; 2004 Aug; 99(8):1042-8. PubMed ID: 15265101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of smoking cessation behaviors and interventions among Latino smokers at low-income clinics in a US-Mexico border county.
    Sias JJ; Urquidi UJ; Bristow ZM; Rodriguez JC; Ortiz M
    Addict Behav; 2008 Feb; 33(2):373-80. PubMed ID: 18006240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of nicotine replacement therapy among smoking-cessation attempters.
    Burns EK; Levinson AH
    Am J Prev Med; 2008 Mar; 34(3):212-5. PubMed ID: 18312809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nicotine replacement therapy in adolescent smokers and nonsmokers.
    Klesges LM; Johnson KC; Somes G; Zbikowski S; Robinson L
    Arch Pediatr Adolesc Med; 2003 Jun; 157(6):517-22. PubMed ID: 12796230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a smoking cessation intervention in older adults.
    Tait RJ; Hulse GK; Waterreus A; Flicker L; Lautenschlager NT; Jamrozik K; Almeida OP
    Addiction; 2007 Jan; 102(1):148-55. PubMed ID: 17207132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant smokers are receptive to smoking cessation advice and use of nicotine replacement therapy.
    Bedford K; Wallace C; Carroll T; Rissel C
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):424-6. PubMed ID: 18837850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation treatment in primary care: prospective cohort study.
    Wilson A; Hippisley-Cox J; Coupland C; Coleman T; Britton J; Barrett S
    Tob Control; 2005 Aug; 14(4):242-6. PubMed ID: 16046686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latinos report less use of pharmaceutical aids when trying to quit smoking.
    Levinson AH; Pérez-Stable EJ; Espinoza P; Flores ET; Byers TE
    Am J Prev Med; 2004 Feb; 26(2):105-11. PubMed ID: 14751320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco cessation drug therapy among Canada's Aboriginal people.
    Wardman D; Quantz D; Tootoosis J; Khan N
    Nicotine Tob Res; 2007 May; 9(5):607-11. PubMed ID: 17454717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.